NEW YORK A massive California verdict in a lawsuit alleging Johnson & Johnson's talc-based products cause cancer has opened a new front in the litigation, upending the company's hopes that the cases were only gaining traction in Missouri, legal experts said.
- Coca-Cola, PespiCo and others agree to cap sugar in drinks in Singapore
- Philip Morris International CEO cheers U.S. FDA tobacco proposal
- India grants Pfizer patent on pneumonia vaccine in blow to aid group
- Using unproven methods to tackle cancer could be deadly
- Changing childcare settings can affect sleep
(Reuters Health) - Voters in counties where life expectancy has stagnated and declined in recent years were more likely to abandon the Democratic Party to help elect U.S. President Donald Trump, a new study suggests.
(Reuters Health) - People who’d like to reduce their daily calories without restrictive dieting should consider taking their coffee with little or no sugar - and savoring the beverage might help in that regard, researchers suggest.
Reuters Health - In two-physician couples, women with kids work fewer hours than women without children, a recent U.S. study suggests.
FRANKFURT AstraZeneca has stepped up its investment in messenger RNA drugs, a promising approach in genetic therapy, by spending more than 25 million euros ($29 million) on a research alliance with German biotech start-up Ethris.